single5MG
DSIP
5MG Protocol
DSIP 5MG
Injection Freq.
Inject once daily
Cycle Sched.
4–8 weeks; optional extension to 12 weeks with periodic breaks
Reconstitution
3.0 mL BAC water
May increase slow-wave (delta) sleep and improve subjective sleep quality
Potential stress-protective / anxiolytic-like effects described
Some studies suggest lack of pharmacologic tolerance with continued use (as cited)
1
Reconstitution Requirements
- 3.0 mL BAC water
Escalation steps: 4
Defined through week 8
| Step | Week Range | Dose | Units |
|---|---|---|---|
| 1 | Weeks 1–1 | 100 mcg | 6 |
| 2 | Weeks 2–2 | 150 mcg | 9 |
| 3 | Weeks 3–3 | 200 mcg | 12 |
| 4 | Weeks 4–8 | 250–300 mcg | 18 |
Inject once daily
4–8 weeks; optional extension to 12 weeks with periodic breaks
Delta Sleep-Inducing Peptide (DSIP) is described as a naturally occurring 9–amino-acid peptide investigated for its role in sleep architecture and stress physiology. In the protocol, DSIP’s mechanistic narrative focuses on neuromodulatory effects rather than sedation: research is described suggesting DSIP can influence GABAergic signaling and interact with opioid-receptor systems, with downstream effects on sleep-stage regulation. The page notes that DSIP has been associated with increased delta-wave (slow-wave) sleep duration without major disruption of REM structure in cited work. Beyond sleep, the protocol highlights ‘adaptogenic’ and stress-protective effects reported in models of hypothalamic–pituitary–adrenal (HPA) axis modulation, including effects on cortisol/ACTH dynamics under stress. The overall framing is that DSIP may support deeper, restorative sleep and stress resilience when used consistently, while acknowledging that long-term human data are limited and periodic breaks are recommended as a precaution.
Mild injection-site reactions (redness/itching)
Limited long-term safety data
periodic breaks recommended (per page)
- Use aseptic technique: wipe vial stopper with alcohol; use new sterile syringe/needle
- Add diluent slowly down the vial wall to minimize foaming
- Gently swirl/roll until fully dissolved (do not shake)
- Label vial with reconstitution date and concentration; protect from light
- Refrigerate after reconstitution (commonly 2–8 °C) unless protocol states otherwise
- Avoid repeated freeze–thaw cycles
- Bacteriostatic Water for Injection contains benzyl alcohol preservative (multi-dose); follow protocol for beyond-use (many peptide protocols use ~28 days after mixing)
- Avoid benzyl-alcohol-containing diluents in neonates/infants (safety warning for benzyl alcohol)